2nd Edition of Cell & Gene Therapy World Conference(CGTWC) 2026

Scientific Sessions

Advancements in Non Viral Gene Delivery Systems

Non-viral gene delivery systems, such as liposomes, nanoparticles, and electroporation, enable introducing genetic material into cells without using viral vectors. Among the challenges are low transfection efficiency, delivery system instability, and trouble obtaining targeted delivery. Researchers are focusing on increased formulation techniques, surface changes to increase cellular acceptance, and targeted ligand delivery to specific kinds of cells at Cell & Gene Therapy World Conference 2026

Related Sessions

CRISPR Cas9 and Beyond: Emerging Genome Editing Platforms
Precision Genome Editing: From Target Discovery to Clinical Application
Engineering the Immune System: Gene and Cell Based Modulation
Non Viral Gene Delivery Strategies: Safety, Scalability, and Translation
Stem Cell Derived Therapeutics: iPSCs, Organoids and Tissue Engineering
Allogeneic vs Autologous Cell Therapies: Manufacturing, Efficacy, and Access
Manufacturing for Personalized Medicine: Customised Cell Products at Scale
Analytics, Potency Assays, and Rapid Release Strategies
CGTs for Monogenic Disorders: Delivering the Cure
Gene and Cell Therapies in Oncology: CAR T, NK, TCR, Oncolytic Approaches
Neurological and Neurodegenerative Disease Applications of CGTs
Market Access, Health Economics, and Reimbursement in CGT
Global Access and Equity: Bridging the CGT Innovation Gap
The Future Landscape of Cell and Gene Therapies: 2030 and Beyond
Cell and Gene Therapy Clinical Development
Cell and Gene Therapy Pipeline Analysis